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A b s t r a c t
Background: The clinical picture of acute pulmonary embolism (APE) is often uncharacteristic and may mimic acute coro-
nary syndrome (ACS) or lung diseases, leading to misdiagnosis. In 50% of patients, APE is accompanied by chest pain and in
30–50% of the patients markers of myocardial injury are elevated.
Aim: To perform a retrospective assessment of how often clinical manifestations and investigations (ECG findings and elevat-
ed markers of myocardial injury) in patients with APE may be suggestive of ACS.
Methods: We included 292 consecutive patients (109 men and 183 women) from 17 to 89 years of age (mean age 65.4 ±
± 15.5 years) with APE diagnosed according the ESC guidelines.
Results: Among the 292 patients included in the study 33 patients died during hospitalisation (mortality rate 11.3%) and
73 (25.0%) patients developed complications. A total of 75 (25.7%) patients were classified as high risk according to the ESC
risk stratification, 163 (55.8%) as intermediate risk and 54 (18.5%) as low risk. Chest pain on and/or before admission was
reported by 128 (43.8%) patients, including 73 (57.0%) patients with chest pain of coronary origin, 52 (40.6%) patients with
chest pain of pleural origin and 3 patients with pain of undeterminable origin based on the available documentation. A total
of 56 (19.2%) patients had a history of ischaemic heart disease and 5 (1.7%) had a history of myocardial infarction. A total of
8 (2.7%) patients were admitted with the initial diagnosis of ACS. The high-risk group consisted of 15 (20.6%) patients with
a typical retrosternal chest pain and 60 (27.3%) patients without the typical anginal pain. Elevated troponin was observed in
103 (35.3%) patients. The ECG changes suggestive of myocardial ischaemia (inverted T waves, ST-segment depression or
elevation) were observed in 208 (71.2%) patients. The following findings were significantly more common in high-risk versus
non-high-risk patients: ST-segment depression in V4–V6 (42.6% vs 23.9%, p = 0.02), ST-segment elevation in V1 (46.7% vs
20.0%, p = 0.0002) and aVR (70.7% vs 40.1%, p = 0.0007).
Conclusions: One third of patients with APE may present with all the manifestations (pain, elevated troponin and ECG
changes) suggestive of ACS. The ECG changes suggestive of myocardial ischaemia are observed in 70% of the patients with
ST-segment depression in V4–V6 and ST-segment elevation in V1 and aVR being significantly more common in high-risk
vs non-high-risk patients.
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INTRODUCTION
Acute pulmonary embolism (APE) continues to be one of the
leading causes of cardiovascular deaths. The mortality rate in
APE is high, up to 15% in the high-risk group [1]. Initiation of
appropriate treatment is of paramount importance, as it re-
duces mortality to 2–8% [2]. This, however, depends on the
correct diagnosis. The clinical picture of APE is often uncha-
racteristic and may mimic acute coronary syndrome (ACS),
syncope, lung diseases or including infections. Observational
studies have shown that in nearly 50% of the patients APE is
accompanied by chest pain and in 30–50% of the patients
markers of myocardial injury are elevated [3, 4]. The ECG in
APE patients very often reveals changes typical of myocardial
ischaemia [5]. Autopsy studies have shown that APE is cor-
rectly diagnosed in a mere 20% of the patients [6, 7]. Clinical
manifestations, elevated troponin and ECG abnormalities may
all suggest ACS, leading to misdiagnosis, mistreatment and
poor outcomes in this group of patients.
The aim of our study was to retrospectively determine
how often clinical manifestations and investigations (ECG and
elevated levels of myocardial injury markers) in patients with
APE may be suggestive of ACS.
METHODS
Study population
We included in our retrospective study a total of 292 con-
secutive patients (109 men and 183 women) from 17 to
89 years of age (mean age 65.4 ± 15.5 years) hospitalised at
9 cardiology wards between 2005 and 2007, discharged with
the final diagnosis of APE. The mean duration of hospitalisa-
tion was 15 days (range 1–46 days). Table 1 summarises the
clinical characteristics of the patients.
Diagnosis of pulmonary embolism
The diagnosis of PE was made on the basis of the diagnostic
evaluations provided in Table 2, in accordance with the cur-
rent European Society of Cardiology (ESC) guidelines [1].
Multislice spiral computed tomography was the most com-
monly used diagnostic modality in 7 out of the 9 study sites,
while 2 sites most commonly utilised single-slice spiral com-
puted tomography. In 16 patients with cardiogenic shock and/
/or significant hypotension (the high-risk group according to
the ESC risk stratification) the diagnosis of APE was made on
the basis of echocardiographic signs of right ventricular dys-
function.
ECG analysis
We evaluated the first available 12-lead ECG obtained be-
cause of the signs and symptoms that prompted hospitalisa-
tion (ECG recorded at paper speeds of 25 mm/s or 50 mm/s,
calibrated at 10 mm/mV). The ECG were reviewed for in-
verted T waves in III and aVF; inverted T waves in V2–V4;
ST-segment depression in V4–V6; ST-segment elevation in
aVR, III, V1 and V2–V4. The ST-segment depression or ele-
vation was defined as an upward or downward excursion of
the J point by at least 1 mm, respectively. The ST-segment
depression was considered significant if it was present in at
least two of the leads V4–V6. A T wave was considered in-
verted if its amplitude was at least 1 mm. Patients with left
bundle branch block or a pacemaker were not included in
the study.
Markers of myocardial injury
Troponin T or troponin I were determined, depending on
the study site. The following (manufacturer) kits were used
for troponin determinations (the cut-off values for positive
troponin are given in brackets): troponin T (cut-off value
0.03 µg/L) measured by an electro-chemiluminescence
Table 2. Investigations performed to detect acute pulmonary
embolism
Computed tomography 252 (86.3%)
Echocardiography: 24 (8.2%)
Right ventricular dysfunction 16
Embolic material/thrombi 8
Venous Doppler ultrasound 9 (3.0%)
Scintigraphy 5 (1.7%)
Autopsy 2 (0.7%)
Table 1. Demographic and clinical characteristics of patients
with acute pulmonary embolism
Age [years] 65.4 ± 15.5
Male-to-female ratio 109/183 (37.3%/62.7%)
Chest pain: 128 (43.8%)
of coronary origin 73 (57.0%)
of pleural origin 52 (40.6%)




Lower limb thrombophlebitis 136 (46.6%)
Haemoptysis 10 (3.4%)
Cancer 22 (7.5%)
HRT/hormonal contraception 8 (2.7%)
NYHA class III/IV CHF 36 (12.3%)
Chronic obstructive pulmonary disease 24 (8.2%)
Low-grade fever for diagnosis 36 (12.2%)
Duration of hospitalisation [days] 15,08
CHF — chronic heart failure; HRT — hormone replacement therapy;
NYHA — New York Heart Association
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immunoassay (ECLIA; Roche Diagnostics), troponin I (cut-
off value 0.4 µg/L) measured by ECLIA; Roche Diagnostics,
troponin I (cut-off value < 0.1 µg/L; Abbott), troponin I
(cut-off value < 0.1 µg/L) by enzyme immunoassay
(bioMérieux).
Statistical analysis
Continuous variables with a normal distribution are presen-
ted as mean ± SD. Qualitative variables were compared using
the c2 test (with Yates correction in cases of small sizes).
A p value < 0.05 (two-sided) was considered significant. The
statistical calculations were performed using Statistica PL v6.1
(StatSoft, Inc.).
RESULTS
Out of the 292 patients included in the study, 33 patients
died in hospital (mortality rate 11.3%), including 26 (8.9%)
deaths directly attributable to PE. In-hospital complications
were observed in 73 (25.0%) patients. A total of 75 (25.7%)
patients were classified as high risk according to the ESC risk
stratification, 163 (55.8%) as intermediate risk and 54 (18.5%)
as low risk. All-cause mortality in the high-, intermediate- and
low-risk groups was 32.0%, 5.5% and 0.0%, respectively, while
mortality directly attributable to PE was 29.3%, 3.0% and
0.0%, respectively.
Chest pain
Chest pain on and/or before admission was reported by 128
(43.8%) patients. Based on the available documentation we
found that chest pain was most commonly of coronary ori-
gin, less frequently of pleural origin and least frequently of
undeterminable origin (Table 1).
In the entire study population, 56 (19.2%) patients had
a history of coronary artery disease (CAD) and 5 (1.7%) had
a history of myocardial infarction. A total of 8 (2.7%) patients
were admitted with the initial diagnosis of ACS and received
dual antiplatelet therapy and low-molecular-weight heparin,
2 patients underwent urgent coronary angiography and 1 pa-
tient died during the 30-day follow-up. Ten (13.7%) patients
with a typical chest pain of coronary origin and 11 (20.0%)
patients with chest pain of non-coronary origin had a history
of CAD. Thirty-six (21.9%) patients without chest pain had
a history of CAD. The high-risk group included 15 (20.6%)
patients with a typical retrosternal pain and 60 (27.3%) pa-
tients without a typical chest pain of coronary origin.
In 85 (66.4%) patients with chest pain ischaemic changes
in ECG were observed. The most common ischaemic changes
in ECG observed in patients with chest pain included: inverted
T waves in III and aVF (56 [43.8%] patients) and inverted
T waves in V2–V4 (48 [37.5%] patients). Elevated troponin was
found in 44 (34.8%) patients with chest pain.
ECG changes suggestive of myocardial ischaemia
The ECG changes suggestive of myocardial ischaemia, name-
ly inverted T waves in III, aVF and V2–V4, ST-segment de-
pression or elevation in III, V1, V2–V4, were observed in 208
(71.2%) patients. The incidence of ECG changes typical for
ischaemia is summarised in Table 3.
The most common ECG abnormalities were inverted
T waves in III and aVF, inverted T waves in V2–V4 and ST-seg-
ment depression in V4–V6. Simultaneous presence of inver-
ted T waves in III, aVF and V2–V4 was observed in 80 (27.4%)
patients (Table 3). The right bundle branch block was obse-
rved in 35 (11.9%) patients.
In the high-risk group of patients the following were si-
gnificantly more common than in the non-high risk group:
ST-segment depression in V4–V6, ST-segment elevation in
V1 and aVR (Table 4).
Markers of myocardial injury: troponin
Troponin was measured in 224 (76.7%) patients and was
elevated in 103 (45.9%). In the subgroup of patients in whom
troponin was measured on admission, all the three symp-
toms suggestive of ACS, namely chest pain, ischaemic chan-
ges in ECG and elevated troponin, were observed in
38 (16.9%) patients.
Table 3. The incidence of ECG changes suggestive of myocardial
ischaemia in patients with acute pulmonary embolism
T wave inversion in III and aVF 142 (48.6%)
T wave inversion in V2–V4 122 (41.8%)
ST-segment depression in V4–V6 77 (26.4%)
ST-segment elevation in V1 74 (25.3%)
ST-segment elevation in III 39 (13.3%)
Table 4. Ischaemic ECG changes by risk subgroup
ECG change High-risk Non-high-risk P
T wave inversion in V2–V4 43 (57.3%) 101 (38.9%) NS
ST-segment depression in V4–V6 32 (42.6%) 62 (23.9%) 0.02
ST-segment elevation in III 16 (21.3%) 29 (11.1%) NS
ST-segment elevation in V1 35 (46.7%) 52 (20.0%) 0.0002
ST-segment elevation in aVR 53 (70.7%) 104 (40.1%) 0.0007
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In 44 (19.6%) patients, both chest pain and elevated tro-
ponin level were present. In 90 (40.2%) patients both eleva-
ted troponin and ischaemic ECG changes were present. Thir-
teen (12.6%) patients with elevated troponin level did not
have any ischaemic changes on ECG. In the 103 patients with
elevated troponin, the most common ischaemic ECG chan-
ges were inverted T waves in III and aVF (63 [61.1%] patients)
and inverted T waves in V2–V4 (58 [56.3%] patients).
DISCUSSION
The course of APE is characterised by a plethora of symp-
toms and may be extremely insidious. The principal clinical
manifestations of APE include dyspnoea (80% of the patients)
and chest pain (64%) [8, 9]. Electrocardiogram is one of the
first examinations that are performed in patients hospitalised
for chest pain or dyspnoea. Łabyk et al. [10] found that the
diagnostic criteria of ACS (at least 2 of the following: chest
pain, signs of myocardial ischaemia on ECG and elevated tro-
ponin) were observed in 36% of the patients. They found ele-
vated troponin level in 68% of the patients with chest pain
and inverted T waves on ECG [10]. It should be noted that
Łabyk et al. [10] analysed ischaemic ECG changes without
taking ST-segment elevation into account. Kostrubiec et al.
[11] showed that inverted T waves and ST-segment depres-
sion are significantly more common in patients with APE and
elevated troponin concentration than in patients with nor-
mal troponin levels (97% vs 75%).
Electrocardiogram in patients with APE very often mi-
mics myocardial infarction of the inferior wall with persistent
ST-segment elevation (the so-called inferior wall pseudoin-
farction). In addition to ST-segment elevation in III, there is
also ST-segment elevation in V1. This results from the fact
that lead V1 (V2) reflects processes occurring in the anterior
part of the right ventricle, while the lead III overlies the infe-
rior part of the right ventricle [12]. In our study, 13% of pa-
tients had ST-segment elevation in III.
The ST-segment elevation in V1–V4 can also be obse-
rved in APE [13–15]. We detected ST-segment elevation in
V1 in 24% of our patients. Kucher et al. [16] found ST-seg-
ment elevation in V1 in 20% of the patients.
Ferrari et al. [17] observed inverted T waves in precordial
leads in 68% of the patients with APE, while Geibel et al. [18]
found that 45% of the patients had inverted T waves in
V2–V3 and 35% in V4–V6. Punukollu et al. [19] observed
inverted T waves in V1–V3 in 43% of the patients. We found
inverted T waves in V1–V3 in 41% of our patients.
Geibel et al. [18] found ST-segment depression in I, II
and V4–V6 in 39% of the patients, while we observed ST-
-segment depression in V4–V6 in 26% of our patients, simi-
larly to Kaczyńska et al. (24%) [20]. These changes were
significantly more common in the subgroup of patients
with elevated troponin T vs patients without elevated enzymatic
markers of myocardial injury (41.4% vs 0.0%, p = 0.004) [20].
The ST-segment depression was also significantly more com-
monly associated with death and in-hospital complications [20].
Our aim was to draw the physician’s attention to cases
of APE that mimic ACS, most commonly in the form of non-
ST-elevation myocardial infarction (NSTEMI) [21, 22] and very
rarely in the form of ST-elevation myocardial infarction [23,
24]. Such cases of APE are often associated with poor outco-
mes despite correct early diagnosis. Examples include patients
with clinical symptoms (chest pain), ECG signs (inverted
T waves in leads overlying the inferior wall, the anterior wall or
the inferior and anterior wall) and biochemical manifestations
(elevated troponin), typical of ACS. In our study, as many as
71% of the patients had ischaemic ECG abnormalities on ad-
mission (inverted T waves in leads overlying the inferior wall,
inverted T waves in V2–V4, ST-segment depression, ST-seg-
ment elevation) suggestive of ACS. Nearly 44% of the patients
on admission were experiencing chest pain or had a history
of chest pain with chest pain of coronary origin being identi-
fied in 57% of them. Troponin was elevated in 35% of the
patients. This combination of signs and symptoms results in
a very frequent diagnosis of ACS, most commonly NSTEMI, and
in referring patients for invasive coronary evaluation. Initial
treatment with low-molecular-weight or unfractionated he-
parin improves their clinical condition. Coronary angiogra-
phy shows normal coronary vessels or insignificant atherosc-
lerotic lesions, and such patients, given the initial and subse-
quently confirmed diagnosis of ACS, fail to receive antith-
rombotic therapy (as they should if they had a diagnosis of
PE), and instead they are put on antiplatelet treatment (as is
appropriate in ACS patients) [25]. This misdiagnosis and mi-
streatment may, in the worst-case scenario, lead to sudden
death, which is why every patient with an initial diagnosis of
ACS and normal (or near-normal) angiographic picture of the
coronary vessels should undergo a thorough diagnostic eva-
luation for APE.
CONCLUSIONS
1. One third of patients with APE may present with all the
manifestations (pain, elevated troponin and ECG chan-
ges) suggestive of ACS.
2. The ECG changes suggestive of myocardial ischaemia are
observed in 70% of the patients.
3. ST-segment depression in V4–V6 and ST-segment ele-
vation in V1 and aVR are significantly more common in
high-risk vs non-high-risk patients.
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S t r e s z c z e n i e
Wstęp: Obraz kliniczny ostrego zatoru tętnicy płucnej (OZTP) jest często niecharakterystyczny i może występować pod maską
ostrego zespołu wieńcowego (OZW) czy chorób płuc, co prowadzi do pomyłek diagnostycznych. U 50% chorych OZTP prze-
biega z bólem w klatce piersiowej, a u 30–50% osób obserwuje się podwyższenie markerów uszkodzenia miokardium.
Cel: Celem pracy było retrospektywne określenie, jak często objawy kliniczne i badania dodatkowe (elektrokardiogram
i podwyższone stężenie markerów martwicy mięśnia sercowego) u chorych z OZTP mogą sugerować rozpoznanie OZW.
Metody: Do badania włączono 292 kolejnych chorych (183 kobiety, 109 mężczyzn) w wieku 17–89 lat (średni wiek 65,4 ±
± 15,5 roku) z rozpoznaniem OZTP.
Wyniki: W grupie 292 chorych w trakcie hospitalizacji wystąpiły 33 zgony (śmiertelność 11,3%), a u 73 (25%) pacjentów
zaobserwowano powikłania. Do grupy wysokiego ryzyka wg stratyfikacji ryzyka ESC zaliczono 75 (25,7%) chorych, do grupy
umiarkowanego ryzyka — 163 (55,8%) osób, a do grupy niskiego ryzyka — 54 (18,5%) pacjentów. Ból w klatce piersiowej
przy przyjęciu i/lub przed przyjęciem do szpitala podawało 128 (43,8%) chorych, w tym u 73 (57,0%) osób ból miał charak-
ter wieńcowy, u 52 (40,6%) — opłucnowy, u 3 —  nieokreślony na podstawie dostępnej dokumentacji. W całej badanej
grupie 56 (19,2%) osób miało wywiad choroby niedokrwiennej serca, a 5 (1,7%) chorych przebyło zawał serca. Ze wstępnym
rozpoznaniem OZW przyjęto 8 (2,7%) chorych. Do grupy wysokiego ryzyka należało 15 (20,6%) osób z typowym bólem
zamostkowym oraz 60 (27,3%) pacjentów bez typowego bólu wieńcowego. U 103 (35,3%) chorych stwierdzono podwyż-
szone stężenie troponiny. Zmiany elektrokardiograficzne sugerujące niedokrwienie mięśnia sercowego (ujemne załamki T,
obniżenie odcinka ST lub uniesienie odcinka ST) zaobserwowano u 208 (71,2%) chorych. W grupie pacjentów wysokiego
ryzyka znamiennie częściej stwierdzano: obniżenie odcinka ST w odprowadzeniach V4–V6 (42,6% v. 23,9%; p = 0,02),
uniesienie odcinka ST w odprowadzeniu V1 (46,7% v. 20%; p = 0,0002) i aVR (70,7% v. 40,1%; p = 0,0007) w porównaniu
z chorymi z grupy niewysokiego ryzyka.
Wnioski: U 1/3 chorych z OZTP mogą występować wszystkie objawy (ból, podwyższone stężenie troponiny i zmiany elektro-
kardiograficzne) sugerujące rozpoznanie OZW. Zmiany elektrokardiograficzne sugerujące niedokrwienie mięśnia sercowego
występują u 70% pacjentów. W grupie osób wysokiego ryzyka znamiennie częściej obserwowano obniżenie odcinka ST
w odprowadzeniach V4–V6 oraz uniesienie odcinka ST w odprowadzeniach V1 i aVR.
Słowa kluczowe: ostry zator tętnicy płucnej, ostry zespół wieńcowy, EKG
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